Nosál R, Pecivová J, Drábiková K
Agents Actions. 1985 Sep;16(6):478-84. doi: 10.1007/BF01983650.
The interaction of beta-adrenoceptor blocking drugs (BAB drugs) with isolated mast cells resulted, according to the compound, in either a liberation of biogenic amines or an inhibition of stimulated amine release. The liberatory drugs exaprolol and Kö 1124 decreased the level of cAMP, stimulated the activity of cyclic nucleotide-phosphodiesterase, decreased the incorporation of orthophosphate into membrane phospholipids and rapidly displaced calcium from binding sites in mast cells. The inhibitory drugs alprenolol, metipranolol, oxprenolol, practolol and propranolol, possessing lower liposolubility, produced opposite effects. Drugs from both groups displaced histamine from binding sites in isolated mast cell granules. The interaction of BAB drugs with mast cells is a result of non-specific rather than specific receptor interactions. Inhibitory drugs interfere with mast cells at membrane sites while liberatory drugs penetrate the membrane, thus acting both at the level of membrane and intracellularly.
β-肾上腺素能受体阻断药(BAB 药)与分离的肥大细胞相互作用时,根据化合物的不同,要么导致生物胺释放,要么抑制刺激引起的胺释放。释放性药物艾司洛尔和 Kö 1124 降低了环磷酸腺苷(cAMP)水平,刺激了环核苷酸磷酸二酯酶的活性,减少了正磷酸盐掺入膜磷脂,并迅速使肥大细胞结合位点上的钙移位。抑制性药物阿普洛尔、美替洛尔、氧烯洛尔、普拉洛尔和普萘洛尔,脂溶性较低,产生相反的作用。两组药物都使组胺从分离的肥大细胞颗粒中的结合位点上移位。BAB 药与肥大细胞的相互作用是非特异性而非特异性受体相互作用的结果。抑制性药物在膜位点干扰肥大细胞,而释放性药物穿透膜,从而在膜水平和细胞内发挥作用。